Dianthus Therapeutics Inc. (DNTH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.17B
Last updated: Nov 17, 2026 at 11:03 AM ET
Dianthus Therapeutics Inc. (DNTH) Competitors
The companies most similar to Dianthus Therapeutics are TG Therapeutics (TGTX), Dyne Therapeutics (DYN) and Protagonist Therapeutics (PTGX). By market cap, Dianthus Therapeutics ranks 5th of the 13 companies on this page; TG Therapeutics (TGTX) is the largest at $9.75B.
Peer Comparison
DNTH's revenue growth of 205.6% is above the peer median of 11.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | $5.17B | N/A | N/A | 0.0% | N/A | 205.6% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Dyne Therapeutics Inc (DYN) | $3.22B | N/A | N/A | 0.0% | -42.9% | 0.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Disc Medicine Inc. (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| PTC Therapeutics Inc (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Denali Therapeutics Inc (DNLI) | $3.00B | N/A | 159.3x | 0.0% | N/A | -100.0% | 0.00% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tango Therapeutics Inc (TNGX) | $4.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Telix Pharmaceuticals Limited (TLX) | $3.14B | N/A | 5.3x | 3.8% | -0.7% | 22.3% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Ionis Pharmaceuticals Inc (IONS) | $4.84B | N/A | 4.8x | -56.9% | -29.3% | 54.9% | 0.00% |
| Peer median | $4.58B | 57.5x | 9.2x | 0.0% | -26.2% | 11.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Dianthus Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Dyne Therapeutics Inc (DYN) | Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases... | DYN competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Disc Medicine Inc. (IRON) | Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development... | IRON competitors |
| PTC Therapeutics Inc (PTCT) | PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. | PTCT competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Denali Therapeutics Inc (DNLI) | Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. | DNLI competitors |
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| Tango Therapeutics Inc (TNGX) | Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation... | TNGX competitors |
| Telix Pharmaceuticals Limited (TLX) | Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic... | |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Ionis Pharmaceuticals Inc (IONS) | Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California. | IONS competitors |
Frequently Asked Questions About DNTH
Who are Dianthus Therapeutics' main competitors?
The companies most similar to Dianthus Therapeutics include TG Therapeutics (TGTX), Dyne Therapeutics (DYN), Protagonist Therapeutics (PTGX), Disc Medicine (IRON) and PTC Therapeutics (PTCT), listed from the closest match.
Who is Dianthus Therapeutics' biggest competitor?
TG Therapeutics (TGTX) is both the largest of the similar companies at $9.75B and the closest match by business profile, size, sector and industry.
How does DNTH stock compare with its competitors?
DNTH's net margin is 0.0% against a peer median of 0.0%.
Which of Dianthus Therapeutics' competitors pays a higher dividend?
Dianthus Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Dianthus Therapeutics bigger than its competitors?
No. Dianthus Therapeutics is 5th by market cap among the 13 companies on this page; the largest is TG Therapeutics (TGTX) at $9.75B.
DNTH pages: Overview, Earnings, Forecast, Financials, Competitors